Working to Eradicate Gynecologic Cancers

Kristin K. Zorn, MD

Associate Professor
University of Arkansas for Medical Sciences
Division of Gynecologic Oncology
4301 W. Markham, Slot 793
Little Rock, AR
USA 72205

Papers:
367 Phase I study of intravenous (IV) oxaliplatin and intraperitoneal (IP) docetaxel in recurrent ovarian and primary peritoneal cancer Targeting genetic defects in DNA repair in patients with ovarian cancer